evaluate the digital health company rexmd on wegovy / semaglutide U.S. FDA | FDA has approved a new higher dose (7.2 mg) of ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Weight Management Program for Men

Importantly, GLP-1 RAs should be prescribed and managed by clinicians experienced in pediatric obesity (e.g., pediatric endocrinologists or obesity specialists) because of dosing complexities and the need for growth monitoring

L., Purnell P

Oliver Philps is an experienced medicinal chemist who has worked for a diverse range of biotechnology and pharmaceutical companies throughout his career (including Vertex Pharmaceuticals, GSK, AstraZeneca and Eisai)

So a bunch of different scientists started testing it in Petri dishes and in animals, and it turns out GLP-1 increases insulin release and lowers blood sugar and slows the rate the stomach empties out and makes people feel more full and eat less, exactly the things that could help treat type two diabetes